LSBCF (LakeShore Biopharma Co) Other Operating Expense: $1.99 Mil (TTM As of Mar. 2025)


What is LakeShore Biopharma Co Other Operating Expense?

LakeShore Biopharma Co LSBCF Other Operating Expense is $1.99 Mil as of Mar. 2025.

LakeShore Biopharma Co's Other Operating Expense for the six months ended in Mar. 2025 was $2.54 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was $1.99 Mil.

LakeShore Biopharma Co's quarterly Other Operating Expense declined from Mar. 2024 ($1.00 Mil) to Sep. 2024 ($-0.55 Mil) but then increased from Sep. 2024 ($-0.55 Mil) to Mar. 2025 ($2.54 Mil).

LakeShore Biopharma Co's annual Other Operating Expense increased from Mar. 2023 ($-1.92 Mil) to Mar. 2024 ($-1.04 Mil) and increased from Mar. 2024 ($-1.04 Mil) to Mar. 2025 ($2.01 Mil).

LakeShore Biopharma Co Other Operating Expense Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Other Operating Expense Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Other Operating Expense
2.60 -1.84 -1.92 -1.04 2.01

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only 1.34 -2.00 1.00 -0.55 2.54

LakeShore Biopharma Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $1.99 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of $1.99 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Other Operating Expense of $1.99 Mil as of Mar. 2025. Other operating expenses that a company records on its income statement. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Other Operating Expense too high?
LakeShore Biopharma Co's current Other Operating Expense is $1.99 Mil.
How does LakeShore Biopharma Co's Other Operating Expense compare to ACUT and PPCB?
LakeShore Biopharma Co's Other Operating Expense of $1.99 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Other Operating Expense is $1.99 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Other Operating Expense of $1.99 Mil. The current Other Operating Expense is $1.99 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Other Operating Expense is $1.99 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.